{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:39:59Z","timestamp":1790429999880,"version":"4.1.0"},"reference-count":101,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The classic gut hormone cholecystokinin (CCK) and its CCK2-receptor are expressed in almost all regions of the brain. This widespread expression makes CCK by far the most abundant peptidergic transmitter system in the brain. This CNS-ubiquity has, however, complicated the delineation of the roles of CCK peptides in normal brain functions and neuropsychiatric diseases. Nevertheless, the common panic disorder disease is apparently associated with CCK in the brain. Thus, the C-terminal tetrapeptide fragment of CCK (CCK-4) induces, by intravenous administration in a dose-related manner, panic attacks that are similar to the endogenous attacks in panic disorder patients. This review describes the history behind the discovery of the panicogenic effect of CCK-4. Subsequently, the review discusses three unsettled questions about the involvement of cerebral CCK in the pathogenesis of anxiety and panic disorder, including therapeutic attempts with CCK2-receptor antagonists.<\/jats:p>","DOI":"10.3390\/molecules26185657","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:13:47Z","timestamp":1631924027000},"page":"5657","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions"],"prefix":"10.3390","volume":"26","author":[{"given":"Jens F.","family":"Rehfeld","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1152\/ajplegacy.1928.86.3.599","article-title":"Hormone mechanism for gallbladder contraction and evacuation","volume":"86","author":"Ivy","year":"1928","journal-title":"Am. J. Physiol."},{"key":"ref_2","unstructured":"Schultz, S.G., Makhlouf, G.M., and Rauner, B.B. (1989). Cholecystokinin. Handbook of Physiology, the Gastrointestinal System: Neural and Endocrine Biology, The American Physiology Society."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fendo.2017.00047","article-title":"Cholecystokinin\u2014From local gut hormone to ubiquitous messenger","volume":"8","author":"Rehfeld","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1530\/EC-21-0025","article-title":"Cholecystokinin and the hormone concept","volume":"10","author":"Rehfeld","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/257604a0","article-title":"New peptide in the vertebrate CNS reacting with antigastrin antibodies","volume":"257","author":"Vanderhaeghen","year":"1975","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/264568a0","article-title":"Immunochemical evidence of cholecystokinin-like peptides in brain","volume":"264","author":"Dockray","year":"1976","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1073\/pnas.74.7.3035","article-title":"Cholecystokinin and its COOH-terminal octapeptide in the pig brain","volume":"74","author":"Strauss","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","first-page":"24","article-title":"Gastrins and cholecystokinins in brain and gut","volume":"41","author":"Rehfeld","year":"1977","journal-title":"Acta Pharmacol. Toxicol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1016\/S0021-9258(17)34793-2","article-title":"Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and the small intestine of man and hog","volume":"253","author":"Rehfeld","year":"1978","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-8993(79)90554-7","article-title":"Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system","volume":"165","author":"Larsson","year":"1979","journal-title":"Brain Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1985.tb29900.x","article-title":"Comparative distribution of cholecystokinin and other neuropeptides: Why is this peptide different from all other peptides?","volume":"448","author":"Crawley","year":"1985","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","first-page":"61","article-title":"Cholecystokinin peptides: Excitatory effect on hippocampal neurons","volume":"195","author":"Dodd","year":"1979","journal-title":"J. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/0024-3205(80)90603-7","article-title":"Cholecystokinin octapeptide: Vesicular localization and calcium dependent release from rat brain in vitro","volume":"26","author":"Emson","year":"1980","journal-title":"Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/274711a0","article-title":"Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain","volume":"274","author":"Dockray","year":"1978","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1016\/S0021-9258(17)38458-2","article-title":"Characterization of preprocholecystokinin products in porcine cerebral cortex: Evidence of different processing pathways","volume":"261","author":"Rehfeld","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.npep.2016.08.003","article-title":"Nonsulfated cholecystokinins in cerebral neurons","volume":"60","author":"Agersnap","year":"2016","journal-title":"Neuropeptides"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0021-9258(18)45976-5","article-title":"Patterns of prohormone processing: Order revealed by a new procholecystokinin-derived peptide","volume":"267","author":"Eberlein","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_18","first-page":"251","article-title":"The predominant cholocystokinin in human plasm and intestine is cholecystokinin-33","volume":"86","author":"Rehfeld","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.peptides.2015.07.010","article-title":"Nonsulfated cholecystokinins in the small intestine of pigs and rats","volume":"71","author":"Agersnap","year":"2015","journal-title":"Peptides"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1210\/en.2007-0278","article-title":"The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1\/3, 2, and 5\/6","volume":"149","author":"Rehfeld","year":"2008","journal-title":"Endocrinology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"LeDoux","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.mp.4000812","article-title":"The amygdala: Vigilance and emotion","volume":"6","author":"Davis","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1460-9568.2007.05963.x","article-title":"Role of the amygdoloid cholecystokinin (CCK)\/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H] GABA release","volume":"26","author":"Jacobsen","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1073\/pnas.77.2.1190","article-title":"Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat","volume":"77","author":"Vanderhaeghen","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-8993(03)02625-8","article-title":"Immunohistochemical characterization of cholecystokinin containing neurons in the rat basolateral amygdala","volume":"976","author":"Mascagni","year":"2003","journal-title":"Brain Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1523\/JNEUROSCI.03-04-00877.1983","article-title":"Autoradiographic localization of cholecystokinin receptors in rodent brain","volume":"3","author":"Zarbin","year":"1983","journal-title":"J. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/mcne.1993.1018","article-title":"Differential expression of CCK(A) and CCK(B) receptors in the rat brain","volume":"4","author":"Honda","year":"1993","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(00)01504-4","article-title":"Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using antipeptide antibodies","volume":"293","author":"Mercer","year":"2000","journal-title":"Neurosci. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3940(94)90681-5","article-title":"Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety","volume":"172","author":"Rex","year":"1994","journal-title":"Neurosci. Lett."},{"key":"ref_31","first-page":"33","article-title":"Cholecystokinin-induced anxiety in rats: Relevance of pre-experimental stress and seasonal variations","volume":"25","author":"Bourin","year":"2000","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/gut.5.2.103","article-title":"The constitution and properties of two gastrins extracted from hog antral mucosa","volume":"5","author":"Gregory","year":"1964","journal-title":"Gut"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/204931a0","article-title":"The antral hormone gastrin. I. Structure of gastrin","volume":"204","author":"Gregory","year":"1964","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/2071356a0","article-title":"Structure-function relationships in the active C-terminal tetrapeptide sequence of gastrin","volume":"207","author":"Morley","year":"1965","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1432-1033.1968.tb00433.x","article-title":"Structure of porcine cholecystokinin\u2014Pancreozymin. I. Cleavage with thrombin and with trypsin","volume":"6","author":"Mutt","year":"1968","journal-title":"Eur. J. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"57P","DOI":"10.1042\/bj1250057P","article-title":"Hormonal polypeptides of the upper intestine","volume":"125","author":"Mutt","year":"1971","journal-title":"Biochem. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/269335a0","article-title":"Evidence for a common evolutionary origin of gastrin and cholecystokinin","volume":"269","author":"Larsson","year":"1977","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/frne.1997.0163","article-title":"Phylogeny of the cholecystokinin\/gastrin family","volume":"19","author":"Johnsen","year":"1998","journal-title":"Front. Neuroendocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MED.0b013e328334e535","article-title":"Evolution of gastrointestinal hormones: The cholecystokinin\/gastrin family","volume":"17","author":"Baldwin","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygcen.2013.10.019","article-title":"Evolution of the gastrin-cholecystokinin gene family by synteny analysis","volume":"195","author":"Tostivint","year":"2014","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jcem-24-10-1076","article-title":"Plasma insulin responses to oral and intravenous glucose administration","volume":"24","author":"Elrick","year":"1964","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(64)90011-X","article-title":"New interpretation of oral glucose tolerance","volume":"2","author":"McIntyre","year":"1964","journal-title":"Lancet"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fendo.2018.00387","article-title":"The origin and understanding of the incretin concept","volume":"9","author":"Rehfeld","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_44","first-page":"169","article-title":"Effect of gastrin and its C-terminal tetrapeptide on insulin secretion in man","volume":"66","author":"Rehfeld","year":"1971","journal-title":"Acta Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1172\/JCI107315","article-title":"The effect of gastrin on basal- and glucose-stimulated insulin secretion in man","volume":"52","author":"Rehfeld","year":"1973","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/284033a0","article-title":"Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK","volume":"284","author":"Rehfeld","year":"1980","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dourish, C.T., Cooper, S.J., Iversen, S.D., and Iversen, L.L. (1992). CCK and anxiety: An introduction. Multiple Cholecystokinin Receptors in CNS, Oxford University Press.","DOI":"10.1093\/oso\/9780198577560.001.0001"},{"key":"ref_48","first-page":"1","article-title":"Neuronal cholecystokinin","volume":"Volume 448","author":"Vanderhaeghen","year":"1985","journal-title":"International Conference on Neuronal Cholecystokinin 1984: Brussels, Belgium"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/312363a0","article-title":"Benzodiazepine antagonizes cholecystokinin-induced activation of rat hippocampal neurons","volume":"321","author":"Bradwejn","year":"1984","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1749-6632.1985.tb29954.x","article-title":"Antagonism of cholecystokinin-induced activation by benzodiazepine receptor antagonists","volume":"448","author":"Bradwejn","year":"1985","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","article-title":"Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers: Preliminary findings","volume":"46","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/070674379003500115","article-title":"Cholecystokinin tetrapeptide induces panic attacks in patients with panic disorders","volume":"35","author":"Bradwejn","year":"1990","journal-title":"Can. J. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder","volume":"48","author":"Bradwejn","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_54","first-page":"260","article-title":"Dose-ranging study of the effect of CCK-4 in healthy volunteers","volume":"16","author":"Bradwejn","year":"1991","journal-title":"J. Psychiatr. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1994.03950060050005","article-title":"The panicogenic effects of cholecystokinin tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder","volume":"51","author":"Bradwejn","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Bradwejn, J., and Vasar, E. (1995). Cholecystokinin and Anxiety: From Neuron to Behavior, R.G. Landes Co.","DOI":"10.1007\/978-3-662-21705-4"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/713783681","article-title":"Cholecystokinin and panic disorder: Past and future clinical research strategies","volume":"61","author":"Bradwejn","year":"2001","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.neubiorev.2005.05.008","article-title":"Cholecystokinin-2 (CCK2) receptor mediated anxiety-like behaviors in rats","volume":"29","author":"Wang","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/da.21919","article-title":"Neuronal network of panic disorder: The role of the neuropeptide cholecystokinin","volume":"29","author":"Zwanzger","year":"2012","journal-title":"Depress. Anxiety"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0893-133X(96)00197-2","article-title":"A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls","volume":"16","author":"McCann","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","article-title":"Behavioural, cardiovascular and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: A comparison of panickers and non-panickers","volume":"8","author":"Koszycki","year":"1998","journal-title":"Depress. Anxiety"},{"key":"ref_62","first-page":"332","article-title":"Effects of citapram treatment on behavioural, cardiovascular, and neuroendocrine response to cholecystokinin tetrapeptide challenge in panic disorder patients","volume":"22","author":"Shlik","year":"1997","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002130050201","article-title":"Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks","volume":"129","author":"Westenberg","year":"1997","journal-title":"Psychoparmacology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0301-0082(95)80007-U","article-title":"Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: Multiple transmitter interaction and neuropeptide colocalizations","volume":"47","author":"Zacharko","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Bradwejn, J., and Vasar, E. (1995). Interactions between cholecystokinin and other neurotransmitter systems. Cholecystokinin and Anxiety: From Neuron to Behavior, R.G. Landes Co.","DOI":"10.1007\/978-3-662-21705-4"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0006-3223(95)00479-3","article-title":"Effect of acute tryptophan depletion on behavioural, cardiovascular and hormonal sensitivity to cholecystokinin-tetrepeptide challenge in healthy volunteers","volume":"40","author":"Koszycki","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-3223(97)00536-2","article-title":"The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms","volume":"44","author":"Bradwejn","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1176\/ajp.152.8.1180","article-title":"Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers","volume":"152","author":"Benkelfat","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0006-3223(98)00348-5","article-title":"Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: A comparison of two time points","volume":"45","author":"Javanmard","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1749-6632.1985.tb29932.x","article-title":"The effects of cholecystokinin-8 in the nucleus tractus solitarius","volume":"448","author":"Foutz","year":"1985","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_71","first-page":"229","article-title":"Pentagastrin has panic-inducing properties in obsessive compulsive disorder","volume":"126","author":"Slaap","year":"1996","journal-title":"Psychopharmacology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-3223(97)00185-6","article-title":"Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls","volume":"42","author":"Westenberg","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1176\/ajp.154.5.700","article-title":"Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder","volume":"154","author":"Lydiard","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.mp.4000705","article-title":"Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter","volume":"5","author":"Hansen","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S","article-title":"Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder","volume":"81","author":"Wang","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-1781(98)00063-8","article-title":"An association of NAG levels and a mutation of the CCK gene in panic disorder patients","volume":"80","author":"Garvey","year":"1998","journal-title":"Psychiatry Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/YPG.0b013e32833511a8","article-title":"Gene variations in the cholecystokinin system in patients with panic disorder","volume":"20","author":"Koefoed","year":"2010","journal-title":"Psychiatr. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-7091-0579-5_17","article-title":"Cholecystokinin- and cholecystokinin-B-receptor gene polymorphism in panic disorder","volume":"68","author":"Schirmacher","year":"2004","journal-title":"J. Neural Transmission. Suppl."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ajmg.10043","article-title":"Association studies of the CT repeat polymorphism in the 5\u2019 upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects","volume":"105","author":"Hattori","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1073\/pnas.81.21.6565","article-title":"Isolation of a large cholecystokinin precursor from canine brain","volume":"81","author":"Eysselein","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-5793(84)81175-8","article-title":"Isolation and characterization of cholecystokinin-58 (CCK-58) from porcine brain","volume":"174","author":"Tatemoto","year":"1984","journal-title":"FEBS Lett."},{"key":"ref_82","first-page":"G272","article-title":"CCK-5: Sequence analysis of a small cholecystokinin from canine brain and intestine","volume":"252","author":"Shively","year":"1987","journal-title":"Am. J. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.neuropharm.2005.11.003","article-title":"Characterisation and differential expression of two very closely related G-protein-coupled receptors, GPR139 and GPR142, in mouse tissue and during mouse development","volume":"50","author":"Urny","year":"2006","journal-title":"Neuropharmacology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","article-title":"Anatomical profiling of G protein-coupled receptor expression","volume":"135","author":"Regard","year":"2008","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2018.10.012","article-title":"The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones","volume":"19","author":"Rudenko","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0016-5085(03)00697-8","article-title":"Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue","volume":"125","author":"Reubi","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1016\/S0021-9258(17)38459-4","article-title":"Accumulation of nonamidated preprogastrin and preprocholecystokinin products in porcine pituitary corticotrophs: Evidence of post-translational control of cell differentiation","volume":"261","author":"Rehfeld","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1073\/pnas.84.9.3019","article-title":"Preprocholecystokinin processing in the normal human anterior pituitary","volume":"84","author":"Rehfeld","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/joe.0.1240501","article-title":"Non-sulphated cholecystokinin in human medullary thyroid carcinomas","volume":"124","author":"Rehfeld","year":"1990","journal-title":"J. Endocrinol."},{"key":"ref_90","first-page":"479","article-title":"Cholecystokinin, gastrin and their precursors in pheochromocytomas","volume":"120","author":"Bardram","year":"1989","journal-title":"Acta Endocrinol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1073\/pnas.86.16.6166","article-title":"Transient expression of the cholecystokinin gene in male germ cells and accumulation of the peptide in the acrosomal granule: Possible role of cholecystokinin in fertilization","volume":"86","author":"Persson","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/clinchem\/44.5.991","article-title":"Accurate measurement of cholecystokinin in plasma","volume":"44","author":"Rehfeld","year":"1998","journal-title":"Clin. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/00365513.2020.1804072","article-title":"Circadian variations in plasma concentrations of cholecystokinin and gastrin in man","volume":"80","author":"Rehfeld","year":"2020","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/245323a0","article-title":"Cholecystokinin elicits satiety in rats with open gastric fistulas","volume":"245","author":"Gibbs","year":"1973","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.7268408","article-title":"Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat","volume":"213","author":"Smith","year":"1981","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0006-3223(94)00190-E","article-title":"A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder","volume":"37","author":"Kramer","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0006-3223(95)00081-X","article-title":"Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers","volume":"38","author":"Bradwejn","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s002130050186","article-title":"The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients","volume":"129","author":"Westenberg","year":"1997","journal-title":"Psychopharmacology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"109761","DOI":"10.1016\/j.pnpbp.2019.109761","article-title":"Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat","volume":"96","author":"Ballaz","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1073\/pnas.77.11.6917","article-title":"Distinct cholecystokinin receptors in brain and pancreas","volume":"77","author":"Innis","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1016\/S0021-9258(18)53076-3","article-title":"The human brain cholecystokinin-B\/gastrin receptor. Cloning and characterization","volume":"268","author":"Lee","year":"1993","journal-title":"J. Biol. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/18\/5657\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:01:36Z","timestamp":1760166096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/18\/5657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":101,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["molecules26185657"],"URL":"https:\/\/doi.org\/10.3390\/molecules26185657","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]}}}